Graphs show the overall survival curves for different subgroup patients with postoperative NLR decreased and increased after RFA.

<p>Graphs show the overall survival curves for different subgroup patients with postoperative NLR decreased and increased after RFA.</p

Graphs show the recurrence free survival curves for patients with preoperative NLR≥1.9 and NLR<1.9.

<p>The difference between groups were not statistically significant (log-rank test, <i>P</i> = 0.859).</p

Graphs show the overall survival curves for patients with preoperative NLR≥1.9 and NLR<1.9.

<p>The difference between groups were statistically significant (log-rank test, <i>P</i> = 0.030).</p

Graphs show the overall survival curves for patients with postoperative NLR decreased and increased after RFA.

<p>The difference between groups were statistically significant (log-rank test, <i>P</i><0.001).</p

Graphs show the recurrence free survival curves for patients with postoperative NLR decreased and increased after RFA.

<p>The difference between groups were statistically significant (log-rank test, <i>P</i><0.001).</p

Cox proportional hazards model of baseline prognosticators for overall survival in 178 patients with small HCC undergoing RFA.

<p>AFP, a-fetoprotein; CI, confidence interval; HBeAg, hepatitis B e-antigen; HR, hazard ratio; NLR, neutrophil-lymphocyte ratio; RFA, radiofrequency ablation.</p

Cox proportional hazards model of baseline prognosticators for new recurrence in 178 patients with small HCC undergoing RFA.

<p>AFP, a-fetoprotein; CI, confidence interval; HBeAg, hepatitis B e-antigen; HR, hazard ratio; NLR, neutrophil-lymphocyte ratio; RFA, radiofrequency ablation.</p

Overall survival and disease-free survival of the entire group.

<p>Overall survival and disease-free survival of the entire group.</p

Patient characteristics(N = 24).

<p>Patient characteristics(N = 24).</p

Details of patients(N = 24).

<p>Details of patients(N = 24).</p